Alesi Surgical raises £7m for international expansion
IW Capital leads the financing, joined by existing investors Mercia and IP Group, as Alesi develops its Ultravision2 surgical smoke-control platform.
Expanding beyond the first-generation system
Alesi Surgical announced a further £7 million financing on April 21, 2026. The investment supports international commercial expansion and development of Ultravision2, extending the business beyond the first-generation system used in laparoscopic surgery.
At the announcement, Mercia reported that the earlier platform had been used in more than 50,000 procedures across Europe, the US and Japan. Ultravision2 had gained regulatory clearance for open surgery, creating a further route into operating theatres. The financing therefore backs expansion of an existing deployed technology as well as continued product development.